Pharmaceutical Companies

FL 2021 Independent Pharmacies

DOJ False Claims Act Anti Kickback

Penalty

$447.2 million

Outcome

Pharmaceutical Companies Pay Over $400 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drugs

Details

Pharmaceutical Companies — DOJ Enforcement (2021)

DOJ took enforcement action against Pharmaceutical Companies in FL in 2021 involving false claims act, anti kickback violations in the Independent Pharmacies sector.

Penalty: $447.2 million

Violation types: False Claims Act, Anti Kickback
Entity type: Pharmacy
Penalty type: Criminal
Location: FL

Source: DOJ Press Release — Pharmaceutical Companies Pay Over $400 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drugs

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation and flag billing anomalies before false claims are submitted. Crucible monitors referral patterns and financial arrangements to flag potential anti-kickback violations.

Source: DOJ Press Release — Pharmaceutical Companies Pay Over $400 Million to Resolve Alleged False Claims Act Liability for Price-Fixing of Generic Drugs

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works